Leigh Richard JR 4
4 · CELL THERAPEUTICS INC · Filed Feb 1, 2005
Insider Transaction Report
Form 4
Leigh Richard E. Jr.
Exec. V.P., General Counsel
Transactions
- Award
Common Stock
2005-01-28+100,000→ 113,300 total
Footnotes (1)
- [F1]The reporting person was granted a restricted stock award 50% of which shall vest 45 days following the achievement of a specific performance event determined by the Company's board of directors (the "Initial Vesting Date"), provided that the reporting person remains employed by the Company on the Initial Vesting Date. The remaining 50% shall vest on the date that the Company receives approval for a new drug application for Xyotax from the Food and Drug Administration (the "Second Vesting Date"); provided that the reporting person is still employed by the Company on the Second Vesting Date and that the Second Vesting Date occurs prior to January 1, 2007. If the specified performance event, and therefore the Initial Vesting Date, does not occur, then 100% of the restricted stock shall become vested on the Second Vesting Date; provided that the reporting person is still employed by the Company on the Second Vesting Date and that the Second Vesting Date occurs prior to January 1, 2007.